life science investing ARS Pharmaceuticals Highlights neffy Regulatory Progress and Reports First Quarter 2024 Financial Results
life science investing ARS Pharmaceuticals Submits Response for neffy® Marketing Authorization Application to EMA's CHMP and Enters License Agreement with CSL Seqirus for Commercialization of neffy in Australia and New Zealand
Homerun Resources Inc. Announces Receipt of a Competitive Budgetary Offer for Latin America's First Dedicated Solar Glass Manufacturing Facility
